Bernard Siegel (attorney)
Bernard Siegel (pronunciation: bur-NARD SEE-gul) is a prominent attorney known for his significant contributions to the field of biotechnology law.
Etymology
The name Bernard is of Germanic origin, derived from the elements bern meaning "bear" and hard meaning "brave, hardy". The surname Siegel is of Jewish (Ashkenazic) origin, derived from the Yiddish word zegel meaning "seal".
Career
Bernard Siegel is the founder and executive director of the Genetics Policy Institute (GPI), a leading policy and advocacy organization in the field of stem cell research. He is also known for his role in the landmark legal case, Moore v. Regents of the University of California, which set important precedents for the ownership of human biological materials.
Related Terms
- Attorney: A person appointed to act for another in business or legal matters.
- Biotechnology law: The branch of law that deals with the legal, ethical, and policy issues arising from biotechnology.
- Genetics Policy Institute (GPI): An organization that promotes and defends the field of stem cell research and its application.
- Stem cell research: A field of study that focuses on stem cells, which have the potential to develop into many different types of cells in the body.
- Moore v. Regents of the University of California: A landmark legal case that set important precedents for the ownership of human biological materials.
External links
- Medical encyclopedia article on Bernard Siegel (attorney)
- Wikipedia's article - Bernard Siegel (attorney)
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski